BACKGROUND: Peritoneal dialysis (PD) is the preferred dialysis modality for many patients with end-stage renal disease (ESRD) in the United States. However, in sharp contrast to the high rates of PD use in other industrialized countries, PD use in the United States is low and decreasing. PD availability is a necessary condition for PD use; however, little is known about the availability and geographic distribution of PD services. This study describes trends in the regional supply of PD services in dialysis facilities between 1995 and 2003. STUDY DESIGN: Longitudinal cohort study. SETTING & PARTICIPANTS: Nonfederal outpatient dialysis facilities treating patients with ESRD in the United States using data from the US Renal Data System. PREDICTORS: Annual ESRD patient and dialysis facility composition in hospital referral regions. OUTCOME: Annual proportion of dialysis facilities offering PD treatment services in hospital referral regions. RESULTS: The average proportion of facilities offering PD services in hospital referral regions was 56% in 1996, which decreased to 47% in 2003. There was geographic variation in PD services, with greater PD availability in metropolitan cities (compared with rural regions) and the Northeast (relative to the South and Midwest). Variation in PD availability was not explained by disease trends or patient characteristics believed to be important for PD use. An increasing regional presence of chain-affiliated facilities was associated with less PD supply. LIMITATIONS: Accuracy of patient registry data, inability to account for consolidation of PD services among chain providers, sensitivity of results to definition of regional markets. CONCLUSIONS: The small and decreasing availability of PD therapy seems counterintuitive given its demonstrated appeal to patients and payers. Further research is needed to investigate dialysis facilities' role in the underuse of a potentially useful therapy. Published by Elsevier Inc.
BACKGROUND: Peritoneal dialysis (PD) is the preferred dialysis modality for many patients with end-stage renal disease (ESRD) in the United States. However, in sharp contrast to the high rates of PD use in other industrialized countries, PD use in the United States is low and decreasing. PD availability is a necessary condition for PD use; however, little is known about the availability and geographic distribution of PD services. This study describes trends in the regional supply of PD services in dialysis facilities between 1995 and 2003. STUDY DESIGN: Longitudinal cohort study. SETTING & PARTICIPANTS: Nonfederal outpatient dialysis facilities treating patients with ESRD in the United States using data from the US Renal Data System. PREDICTORS: Annual ESRDpatient and dialysis facility composition in hospital referral regions. OUTCOME: Annual proportion of dialysis facilities offering PD treatment services in hospital referral regions. RESULTS: The average proportion of facilities offering PD services in hospital referral regions was 56% in 1996, which decreased to 47% in 2003. There was geographic variation in PD services, with greater PD availability in metropolitan cities (compared with rural regions) and the Northeast (relative to the South and Midwest). Variation in PD availability was not explained by disease trends or patient characteristics believed to be important for PD use. An increasing regional presence of chain-affiliated facilities was associated with less PD supply. LIMITATIONS: Accuracy of patient registry data, inability to account for consolidation of PD services among chain providers, sensitivity of results to definition of regional markets. CONCLUSIONS: The small and decreasing availability of PD therapy seems counterintuitive given its demonstrated appeal to patients and payers. Further research is needed to investigate dialysis facilities' role in the underuse of a potentially useful therapy. Published by Elsevier Inc.
Authors: Dana C Miskulin; Klemens B Meyer; Nicolaos V Athienites; Alice A Martin; Norma Terrin; Jane V Marsh; Nancy E Fink; Josef Coresh; Neil R Powe; Mike J Klag; Andrew S Levey Journal: Am J Kidney Dis Date: 2002-02 Impact factor: 8.860
Authors: Helen Lee; Braden Manns; Ken Taub; William A Ghali; Stafford Dean; David Johnson; Cam Donaldson Journal: Am J Kidney Dis Date: 2002-09 Impact factor: 8.860
Authors: Rajnish Mehrotra; Osman Khawar; Uyen Duong; Linda Fried; Keith Norris; Allen Nissenson; Kamyar Kalantar-Zadeh Journal: Am J Kidney Dis Date: 2009-04-08 Impact factor: 8.860
Authors: Rajnish Mehrotra; Melissa Soohoo; Matthew B Rivara; Jonathan Himmelfarb; Alfred K Cheung; Onyebuchi A Arah; Allen R Nissenson; Vanessa Ravel; Elani Streja; Sooraj Kuttykrishnan; Ronit Katz; Miklos Z Molnar; Kamyar Kalantar-Zadeh Journal: J Am Soc Nephrol Date: 2015-12-10 Impact factor: 10.121
Authors: Karen H Costenbader; Amrita Desai; Graciela S Alarcón; Linda T Hiraki; Tamara Shaykevich; M Alan Brookhart; Elena Massarotti; Bing Lu; Daniel H Solomon; Wolfgang C Winkelmayer Journal: Arthritis Rheum Date: 2011-06
Authors: Amy Devlin; Sushrut S Waikar; Daniel H Solomon; Bing Lu; Tamara Shaykevich; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader Journal: Arthritis Care Res (Hoboken) Date: 2011-12 Impact factor: 4.794
Authors: Gabriel Contreras; Javier Pagan; Ruchir Chokshi; Sharad Virmani; Jorge M Diego; Patricia Byers; Tamara Isakova; Jair Munoz Mendoza; Ali Nayer; Jose Roberto Contreras; Gabriel Panama; Oliver Lenz; Maria Carpintero; Timothy Muchayi; David Roth Journal: Clin J Am Soc Nephrol Date: 2014-09-04 Impact factor: 8.237
Authors: Marc Turenne; Regina Baker; Jeffrey Pearson; Chad Cogan; Purna Mukhopadhyay; Elizabeth Cope Journal: Health Serv Res Date: 2017-05-30 Impact factor: 3.402
Authors: Virginia Wang; Cynthia J Coffman; Linda L Sanders; Shoou-Yih D Lee; Richard A Hirth; Matthew L Maciejewski Journal: Clin J Am Soc Nephrol Date: 2018-11-19 Impact factor: 8.237
Authors: Virginia Wang; Matthew L Maciejewski; Cynthia J Coffman; Linda L Sanders; Shoou-Yih Daniel Lee; Richard Hirth; Joseph Messana Journal: Health Serv Res Date: 2016-04-07 Impact factor: 3.402
Authors: Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang Journal: Clin J Am Soc Nephrol Date: 2019-11-21 Impact factor: 8.237